Delineated as the total market value of all outstanding shares of the company, the current market cap for the Novo Nordisk A/S is valued at 116882.3. The prevailing figure will allow the investment community to determine the size of Novo Nordisk A/S in contrast to the sales or total assets figures. As a result, investors will be able to comprehend the basic determinant of asset allocation and all sorts of risk-returns parameters for stocks alongside the stock mutual funds. However, it is a general misunderstanding that a higher share price points towards a larger company where stock price might also misrepresent the definite worth of the organization.
At present, Novo Nordisk A/S has a PE ratio of 27.12 with a forward P/E of 22.98 *. The PEG holds a value of 2.36 * and the P/S ratio is calculated to be 7.08 *, whilst P/B is stated to be 19.88. Novo Nordisk A/S grasps an EPS value of 2.07 * displaying an EPS growth of 34.30% * for this year. Accordingly, the company shows a 34.30% EPS growth for the subsequent year and computes the EPS growth for the past five years at 22.40% *. The EPS growth for the next five years accounts to 11.50% *. Sales growth for the last five years strolls at 12.20% *.
The shares outstanding for Novo Nordisk A/S is levered at 2084.95 *. The Shares Float shows a value of 1306.68 * and the Insider Ownership illustrates 26.40% *.
Novo Nordisk A/S’s ROA is currently valued at 41.50% * with a ROI value of 85.00% *. The Current Ratio parades a figure of 1.3 * and the Quick ratio meanders around 1 *.
Novo Nordisk A/S holds a total Debt Equity of 0.02 * with the Long Term Debt/Equity of 0 *. The company mirrors a Gross Margin of 85.00% indicating an Operating Profit of 45.80% *. As a result, Novo Nordisk A/S attained a Profit Margin of 32.30% *.
The weekly performance of Novo Nordisk A/S is 2.04%, presenting a monthly performance value of 2.54% with the quarterly performance value of 1.79%. Novo Nordisk A/S has an annual performance rate of 4.49% *.
Volatility on a weekly basis sums at 1.39% * together with the monthly volatility of 1.45% *. Novo Nordisk A/S has a 20-Day Simple Moving Average 6.78% * and a 200-Day Simple Moving Average of 3.55% *. The 52-Week High confirms a value of -5.08% * with the 52-Week Low of 24.06% *.
Currently, Novo Nordisk A/S holds a stock price of 56.28 and exhibits a change in price of 0.39%. It has a target price of 60.1 * and started its journey on 01/04/1982 * (IPO Date).